← Patent-cliff monitor small molecule CALDOLOR IBUPROFEN
Loss of exclusivity March 2032 latest FDA-listed patent expiry
Company Cumberland → See this company's full patent-cliff portfolio Drug detail Brand name CALDOLOR Active ingredient IBUPROFEN Strength 800MG/200ML (4MG/ML) Dosage form SOLUTION Route INTRAVENOUS Modality Small molecule FDA approval January 2019 Marketing status RX
Listed patents Patent Expires Type 9072661 March 2032 use U-2264 9072710 March 2032 use U-2266 11806400 March 2032 use U-3746 9012508 September 2030 use U-981 8871810 September 2029 use U-981 8735452 September 2029 use U-981
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.